FDA Investigator Ronald E Lundquist
Ronald E Lundquist has conducted inspections on 2 sites in 1 countries as of 15 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
15 Jan 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Canada
FDA Investigators that have inspected at least one site in common with Ronald E Lundquist:
Anita Verma,
Burnell M Henry,
Christina J Sauder, PhD,
Cynthia Jim, CSO,
Diana Kouiavskaia,
Donald L Lech,
Eric Peng,
Gene D Arcy,
Jacqueline Mdiaz Albertini,
James E Keller, PhD,
James R Evans,
Jennifer L Bridgewater,
Joan Johnson,
Julie D Bringger,
Leslie D Wagner,
Michele L Forster, PhD,
Mihaly S Ligmond,
Nancy T Waites,
Omotunde O Osunsanmi,
Paul W Keller,
Paula A Trost,
Prabhu P Raju,
Roger F Zabinski,
Rose Ashley,
Steven C Derrick,
Susan M Jackson,
Tina Buecklein,
Tina S Roecklein
Ronald E Lundquist's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2013 | FDA 483 | Sanofi Pasteur Limited - Form 483, 2013-09-20 |
September, 2013 | FDA 483 Response | Sanofi Pasteur Limited - Form 483R, 2013-10-11 |
April, 2012 | FDA 483 | Sanofi Pasteur Limited - Form 483, 2012-04-25 |
April, 2012 | EIR | Sanofi Pasteur Limited - EIR, 2012-04-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more